Epoprostenol Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-707

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Epoprostenol (NDC 68083-707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epoprostenol-spl-carton-label-0-5mg (Epoprostenol Spl Carton Label 0 5mg)

Epoprostenol for Injection 0.5 mg (500,000 ng) vial label by Gland Pharma Limited. The sterile, lyophilized powder is for intravenous infusion only and packaged as a single-dose vial. The label includes NDC 68083-707-01, storage instructions to keep at 20 to 25°C, and dosing information referencing full prescribing information. The label features the Gland Pharma logo and manufacturing details in Hyderabad, India.*

FDA Label Image

Epoprostenol-spl-carton-label-1-5mg (Epoprostenol Spl Carton Label 1 5mg)

The packaging label for Epoprostenol for Injection 1.5 mg (1,500,000 ng) per vial, a sterile lyophilized powder for intravenous infusion, manufactured by Gland Pharma Limited. The label includes dosage strength, storage instructions, contents listing epoprostenol sodium, sucrose, glycine, sodium hydroxide, and handling directions. It is a single-dose vial with NDC 68083-642-01 and features barcodes and manufacturer details.*

FDA Label Image

Epoprostenol-spl-container-label-0-5mg (Epoprostenol Spl Container Label 0 5mg)

Label for Epoprostenol for Injection 0.5 mg (500,000 ng) per vial, a sterile, lyophilized powder for intravenous infusion. The single-dose vial label includes storage instructions (20°C to 25°C, protect from light), usage directions, a barcode, and manufacturer Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Epoprostenol-spl-container-label-1-5mg (Epoprostenol Spl Container Label 1 5mg)

Epoprostenol for Injection 1.5 mg per vial label, a sterile, lyophilized product intended for intravenous infusion. The single-dose vial is manufactured by Gland Pharma Limited, Hyderabad, India. The label includes storage instructions and advises discarding any unused portion after reconstitution.*

FDA Label Image

Epoprostenol-spl-structure (Epoprostenol Spl Structure)

Chemical structure of epoprostenol depicting its molecular arrangement including carboxylate, hydroxyl, and alkyl groups, consistent with the active ingredient epoprostenol injection powder for solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.